The invention relates to a stable pharmaceutical composition useful in the treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD) and a novel micronisation process for manufacturing a stable formulation for formoterol or its enantiomers and a carrier/diluent comprising a carbohydrate such as lactose.

 
Web www.patentalert.com

< Composition having effect of moxibustion and press pellet using the same

> Glycopeptide conjugates and uses thereof

> Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)

~ 00584